艾尔建公司(纽约证券交易所:AGN)总部位于爱尔兰都柏林,是一家引领全球制药行业的全新典范——增长型制药公司。艾尔建致力于研发、生产和销售品牌药品、医疗器械以及生物制剂等,以提高患者的生活质量。公司的品牌药产品组合,覆盖了中枢神经系统,眼部治疗,医疗美容,消化,妇科,泌尿和抗感染等领域。“开放科学”研发模式使艾尔建拥有超过70个中后期阶段的在研产品线项目。在全球,艾尔建拥有16,000位员工,业务遍布全球近100个国家和地区。倡导勇往直前,创造生命无限潜能的企业文化。更多信息请浏览www.allergan.com


Allergan plc (NYSE: AGN), headquartered in Dublin, Ireland, is a global pharmaceutical company and a leader in a new industry model – Growth Pharma.  Allergan is focused on developing, manufacturing and commercializing branded pharmaceuticals, devices and biologic products for patients around the world. Allergan markets a portfolio of leading brands and best-in-class products for the central nervous system, eye care, medical aesthetics and dermatology, gastroenterology, women's health, urology and anti-infective therapeutic categories. Allergan is an industry leader in Open Science, the Company’s R&D model, which has led to Allergan building one of the broadest development pipelines in the pharmaceutical industry with 70+ mid-to-late stage pipeline programs in development.


Our Company’s success is powered by our more than 16,000 global colleagues’ commitment to being Bold for Life. With commercial operations in approximately 100 countries. For more information, visit Allergan's website at www.allergan.com.


2018年05月30日

博世

上一篇

下一篇

艾尔建

艾尔建